ClinicalTrials.Veeva

Menu

COVID-19 and Pregnancy Outcomes (COVID&PREG)

N

New University of Lisbon

Status

Unknown

Conditions

Pregnancy Complications
Breastfeeding
Neonatal Infection
Vertical Transmission of Infectious Disease
Coronavirus Infection

Treatments

Diagnostic Test: RT PCR SARS-CoV-2

Study type

Observational

Funder types

Other

Identifiers

NCT04416373
COVID&PREG

Details and patient eligibility

About

This is a multicenter prospective study that aims to investigate the clinical impact of SARS-CoV-2 infection in pregnant women, pregnancy outcomes and perinatal transmission.

Full description

This is a cohort study of pregnant women confirmed positive for SARS-CoV-2 infection. Data will be collected in Portuguese maternities that agreed to collaborate in this study.

Pregnant women are tested during hospital admission by using nasopharyngeal/oral swabs for SARS-CoV-2 RT PCR as part of a universal testing policy. Maternal demographic data (age, comorbidities, parity, smoking habits), COVID-19 related data (symptoms, diagnostic tests, therapy used and ICU admission), gestational age at SARS-CoV-2 confirmed infection, pregnancy outcomes (gestational complications, gestational age at birth, mode of delivery) and neonatal outcome (birthweight and Apgar score, RT PCR neonate results) and breastfeeding strategies will be evaluated.

Enrollment

300 estimated patients

Sex

Female

Ages

16 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: Pregnant women infected with Sars-Cov-2. Delivery at Portuguese maternities.

Exclusion Criteria: RT PCR SARS-CoV-2 negative.

Trial contacts and locations

1

Loading...

Central trial contact

Nadia Charepe, MD,MSc; Alexandra Queirós, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems